Biomanufacturing, Biopharmaceutical, Collaboration, Health

The United States Pharmacopeia (USP), the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) and The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), have announced a research collaboration to assess analytical methods and develop standards for adeno-associated virus (AAV), an...

Announcement, Biomanufacturing, Biopharmaceutical, Innovation, Manufacturing

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

Biomanufacturing, COVID-19

The manufacturing sector is at the center of a stronger, faster, and more coordinated U.S. response to COVID-19 and future pandemics. The National Technology Roadmap for Pandemic Response and Recovery—the first pandemic roadmap driven by the manufacturing sector—outlines a technology-based action plan for strengthening and accelerating U.S...

Biomanufacturing

The U.S. Department of Defense (DoD) has awarded a Cooperative Agreement to establish the Bioindustrial Manufacturing And Design Ecosystem, or BioMADE. Established by the Engineering Biology Research Consortium (EBRC), BioMADE joins eight DoD-sponsored Manufacturing Innovation Institutes (MII) as part of the Manufacturing USA network and becomes...